Arthritic Therapeutic Market Definition
Arthritic therapeutics refer to treatments designed to alleviate symptoms and improve quality of life for individuals with arthritis. This includes medications, physical therapy, and other interventions aimed at reducing pain, inflammation, and joint damage. These therapies can help manage various forms of arthritis, such as osteoarthritis and rheumatoid arthritis.
The main drug classes of arthritic therapeutic are tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, xanthine oxidase inhibitors, and others. Tumor necrosis factor (TNF) inhibitors are a class of drugs that block the action of TNF, a protein involved in inflammation, to treat autoimmune diseases They are administered through oral, parenteral, and topical routes for various types of arthritis, such as psoriatic arthritis, rheumatoid arthritis, osteoarthritis, and gout. These drugs are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
Arthritic Therapeutic Market Segmentation
The arthritic therapeutic market covered in this report is segmented –
1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies